Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped down prior to trading on Monday . The stock had previously closed at $8.74, but opened at $8.08. Curaleaf shares last traded at $8.72, with a volume of 3,814 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Three investment analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Strong Buy”.

Curaleaf Stock Down 2.3%

The business has a 50 day moving average of $7.11 and a 200-day moving average of $7.67. The stock has a market cap of $2.01 billion, a PE ratio of -22.11 and a beta of 1.51. The company has a current ratio of 1.56, a quick ratio of 0.74 and a debt-to-equity ratio of 1.05.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.51. The company had revenue of $324.23 million during the quarter, compared to analysts’ expectations of $316.62 million. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%. Equities research analysts predict that Curaleaf Holdings, Inc. will post -0.31 EPS for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.